🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for GLP1-R-related Disease

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease NCT06725693n/a3 sites📍 Hefei📍 Qingdao📍 Tianjin Tianjin Medical University · Tests: 18F/68Ga-Exendin 4 Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists NCT07006142NA1 site📍 Rochester Mayo Clinic · Tests: Modified Fasting Guidelines Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder NCT06939088Phase 22 sites📍 Aalborg📍 Frederiksberg Anders Fink-Jensen, MD, DMSci · Tests: Tirzepatide, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy